Keros Therapeutics Inc (KROS)

Cost of Revenue

$0.00

Quarterly · Period ending: · USD

KROS logo

KROS Cost of Revenue

Latest reported$0.00
KROS Quarterly Cost of Revenue ($0.00 → $0.00)
High-resolution chart · PNG

KROS cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
403,000
0
395,000
370,000
0
332,000
314,000
0
0
0
551,000
0
0
0
0
0
0
302,000
0
9,983,000
0
0
0
0
0
4,130,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.